HealthSouth Corporation (HLS) Shares Bought by Rothschild Asset Management Inc.
Rothschild Asset Management Inc. raised its position in shares of HealthSouth Corporation (NYSE:HLS) by 0.1% during the third quarter, Holdings Channel reports. The institutional investor owned 189,614 shares of the company’s stock after buying an additional 219 shares during the period. Rothschild Asset Management Inc.’s holdings in HealthSouth Corporation were worth $7,693,000 at the end of the most recent reporting period.
Other large investors have also made changes to their positions in the company. Vanguard Group Inc. raised its stake in shares of HealthSouth Corporation by 2.8% in the second quarter. Vanguard Group Inc. now owns 6,324,892 shares of the company’s stock worth $245,532,000 after buying an additional 170,522 shares in the last quarter. Columbia Wanger Asset Management LLC raised its stake in shares of HealthSouth Corporation by 2.3% in the second quarter. Columbia Wanger Asset Management LLC now owns 3,461,221 shares of the company’s stock worth $134,365,000 after buying an additional 76,594 shares in the last quarter. Lord Abbett & CO. LLC raised its stake in shares of HealthSouth Corporation by 9.2% in the second quarter. Lord Abbett & CO. LLC now owns 3,449,266 shares of the company’s stock worth $133,901,000 after buying an additional 291,169 shares in the last quarter. William Blair Investment Management LLC raised its stake in shares of HealthSouth Corporation by 37.7% in the second quarter. William Blair Investment Management LLC now owns 3,061,817 shares of the company’s stock worth $118,860,000 after buying an additional 837,747 shares in the last quarter. Finally, Allianz Asset Management AG raised its stake in shares of HealthSouth Corporation by 382.0% in the second quarter. Allianz Asset Management AG now owns 716,684 shares of the company’s stock worth $27,822,000 after buying an additional 567,979 shares in the last quarter. 97.10% of the stock is currently owned by institutional investors.
Shares of HealthSouth Corporation (NYSE:HLS) opened at 41.79 on Friday. The stock has a market cap of $3.75 billion, a price-to-earnings ratio of 17.42 and a beta of 0.89. HealthSouth Corporation has a 1-year low of $30.26 and a 1-year high of $43.38. The company has a 50-day moving average price of $41.61 and a 200-day moving average price of $40.75.
HealthSouth Corporation (NYSE:HLS) last released its quarterly earnings data on Thursday, October 27th. The company reported $0.65 earnings per share for the quarter, topping the consensus estimate of $0.60 by $0.05. The firm had revenue of $926.80 million for the quarter, compared to analyst estimates of $448.60 million. HealthSouth Corporation had a net margin of 6.31% and a return on equity of 29.27%. HealthSouth Corporation’s quarterly revenue was up 19.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.52 earnings per share. On average, equities analysts expect that HealthSouth Corporation will post $2.57 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 17th. Investors of record on Tuesday, January 3rd will be paid a dividend of $0.24 per share. The ex-dividend date is Thursday, December 29th. This represents a $0.96 annualized dividend and a yield of 2.30%. HealthSouth Corporation’s dividend payout ratio (DPR) is 40.17%.
ILLEGAL ACTIVITY NOTICE: This piece was originally published by Daily Political and is owned by of Daily Political. If you are viewing this piece on another website, it was illegally copied and reposted in violation of international copyright legislation. The legal version of this piece can be read at http://www.dailypolitical.com/2017/01/14/healthsouth-corporation-hls-shares-bought-by-rothschild-asset-management-inc.html.
HLS has been the topic of a number of analyst reports. RBC Capital Markets reaffirmed an “outperform” rating and issued a $48.00 price objective (up previously from $46.00) on shares of HealthSouth Corporation in a report on Monday, October 31st. Zacks Investment Research lowered HealthSouth Corporation from a “buy” rating to a “hold” rating in a report on Tuesday, December 6th. Mizuho lowered HealthSouth Corporation from a “buy” rating to a “neutral” rating in a report on Wednesday, November 9th. Piper Jaffray Companies initiated coverage on HealthSouth Corporation in a report on Tuesday, January 3rd. They issued a “neutral” rating and a $45.00 price objective on the stock. Finally, Royal Bank Of Canada lifted their price objective on HealthSouth Corporation from $46.00 to $48.00 and gave the company an “outperform” rating in a report on Monday, October 31st. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $46.63.
In other HealthSouth Corporation news, CFO Douglas E. Coltharp acquired 6,450 shares of the company’s stock in a transaction that occurred on Wednesday, November 9th. The shares were purchased at an average price of $39.14 per share, for a total transaction of $252,453.00. Following the completion of the purchase, the chief financial officer now directly owns 104,637 shares in the company, valued at $4,095,492.18. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, COO Mark J. Tarr acquired 6,371 shares of the company’s stock in a transaction that occurred on Wednesday, November 9th. The shares were acquired at an average price of $39.29 per share, for a total transaction of $250,316.59. Following the purchase, the chief operating officer now owns 238,890 shares of the company’s stock, valued at $9,385,988.10. The disclosure for this purchase can be found here. Corporate insiders own 5.00% of the company’s stock.
About HealthSouth Corporation
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in over 30 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company’s segments include inpatient rehabilitation, and home health and hospice.
Want to see what other hedge funds are holding HLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthSouth Corporation (NYSE:HLS).
Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with MarketBeat.com's FREE daily email newsletter.